Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
JJC Moves Forward with Major Technology Overhaul to Modernize College Operations
Chinese networks use U.S. to launder billions for Mexican cartels
Alternative tax-hike ideas emerge to fund Illinois public transit
Kamala Harris pro-union X post inspires major Labor Day backlash
Speaker Mike Johnson says Shreveport ‘Democratic DA’ is to blame for high crime
Trump says he will sign executive order ending mail-in voting
Meeting Summary and Briefs: Joliet Junior College Board of Trustees for August 20, 2025
Everyday Economics: Jobs report takes center stage in week ahead
Legislator warns bad Illinois policy continues to hurt business investment
As summer ends, budget battles and investigations await
Tensions Flare as JJC Chairman Rebukes “Entitlement” After Trustee Lists Demands
Trump’s tariff revenue in doubt after appeals court ruling